ROTE WILLIAM E. (CIK 1698262) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-23). Recent activity: Sell TVTX (9,100 shares), Buy TVTX (14,000 shares), Buy TVTX (20,090 shares), Sell TVTX (12,446 shares), Buy TVTX (60,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-23 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Sell | 9,100 | $355,719 |
| 2026-04-15 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Buy | 14,000 | $0 |
| 2026-02-03 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Buy | 20,090 | $0 |
| 2026-02-03 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Sell | 12,446 | $409,100 |
| 2025-12-29 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Buy | 60,000 | $1.2M |
| 2025-12-29 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Sell | 60,000 | $2.4M |
| 2025-05-05 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Buy | 4,920 | $0 |
| 2025-05-05 | Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | Sell | 3,198 | $67,318 |
| 2025-02-12 | Travere Therapeutics, Inc. (TVTX) | SENIOR VICE PRESIDENT, R&D | Buy | 8,000 | $0 |
| 2025-02-12 | Travere Therapeutics, Inc. (TVTX) | SENIOR VICE PRESIDENT, R&D | Sell | 5,200 | $122,356 |
| 2025-02-04 | Travere Therapeutics, Inc. (TVTX) | SENIOR VICE PRESIDENT, R&D | Buy | 21,500 | $0 |
| 2025-02-04 | Travere Therapeutics, Inc. (TVTX) | SENIOR VICE PRESIDENT, R&D | Sell | 8,951 | $177,051 |
| 2025-01-23 | Travere Therapeutics, Inc. (TVTX) | SENIOR VICE PRESIDENT, R&D | Sell | 2,437 | $47,424 |
Source: SEC Form 4 filings · as of 2026-04-23